TNBI — Tanke Biosciences Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro Cap

Annual income statement for Tanke Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2008 December 31st	2009 December 31st	R2010 December 31st	C2011 December 31st	2012 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0	0	20.1	23.8	28.6
Cost of Revenue
Gross Profit	0	0	7.4	8.77	9.94
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	0.018	0.02	15.7	22.1	24
Operating Profit	-0.018	-0.02	4.37	1.74	4.53
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-0.019	-0.022	4.28	-2.45	0.603
Provision for Income Taxes
Net Income After Taxes	-0.019	-0.022	3.69	-3.14	-0.229
Minority Interest
Net Income Before Extraordinary Items
Net Income	-0.019	-0.022	2.74	-3.14	-0.21
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-0.019	-0.022	2.74	-3.14	-0.21
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.046	-0.054	0.255	-0.24	-0.016
Dividends per Share